Nifty

:

24175.65

Sensex

:

77264.51

84.80 (0.35%)
330.92 (0.43%)

Login

Nifty
Sensex

:
:

24175.65
77264.51

84.80 (0.35%)
330.92 (0.43%)

Orchid Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

62/99

BSE: 524372 | NSE: ORCHPHARMA

Watchlist

NSE BSE

975.60

28-Aug-2026

Open
High
Low
Previous Close

931.9
980
924.95
928.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

63715
61003003.25
1133
480

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,827.43
672.45
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,101.70
N/A
4.48

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.54
15.42
11.45

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-4.25
16.90
5.58

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
20.12

P:E (Median)

8 Years
5 Years
3 Years

34.90
42.22
56.39

P:BV (Average)

8 Years
5 Years
3 Years

2.78
3.30
3.94

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.83
36.11
39.69

Earnings Forecasts:

(Updated: 29-08-2026)

Description 2026 2027 2028 2029
Adj EPS 27 23 332.38 2.3
P/E Ratio 36.13 42.42 2.94 424.17
Revenue 122.41 22.77 - 803.6
EBITDA 1288.5 1933.8 - 37.2
Net Income 101.4 339.5 - -10.2
ROA 46.8 259.5 - -
P/B Ratio - - - 3.39
ROE 3.29 2.86 - -0.7
FCFF 3 13.5 - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - 288

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 304.17 172.93 75.89% 237.61 237.48 0.05% 207.27 217.34 -4.63% 193.52 222.70 -13.10%
Expenses 289.17 158.75 82.15% 208.61 203.14 2.69% 204.43 190.98 7.04% 194.19 193.11 0.56%
EBITDA 15.00 14.18 5.78% 28.99 34.33 -15.55% 2.84 26.37 -89.23% -0.67 29.58 -
EBIDTM 4.93% 8.20% 12.20% 14.46% 1.37% 12.13% -0.35% 13.28%
Other Income 10.05 15.93 -36.91% 13.30 6.26 112.46% 10.59 9.94 6.54% 15.43 7.96 93.84%
Interest 2.21 3.26 -32.21% 3.08 3.98 -22.61% 3.17 3.79 -16.36% 3.73 3.30 13.03%
Depreciation 10.90 8.65 26.01% 9.15 8.76 4.45% 8.97 8.61 4.18% 8.79 8.63 1.85%
PBT 11.94 18.20 -34.40% 30.60 27.85 9.87% -5.83 23.91 - 2.23 25.63 -91.30%
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 11.94 18.20 -34.40% 30.60 27.85 9.87% -5.83 23.91 - 2.23 25.63 -91.30%
PATM 3.92% 10.52% 12.88% 11.73% -2.81% 11.00% 1.15% 11.51%
EPS 2.35 3.59 -34.54% 6.04 5.49 10.02% -1.15 4.72 - 0.44 5.05 -91.29%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 304.17 172.93 75.89% 237.61 237.48 0.05% 207.27 217.34 -4.63% 193.52 222.70 -13.10%
Expenses 290.17 158.75 82.78% 210.74 209.49 0.60% 205.70 190.98 7.71% 195.00 192.36 1.37%
EBITDA 14.00 14.18 -1.27% 26.86 27.98 -4.00% 1.56 26.36 -94.08% -1.48 30.34 -
EBIDTM 4.60% 8.20% 11.31% 11.78% 0.75% 12.13% -0.76% 13.62%
Other Income 1.83 11.45 -84.02% 7.34 3.90 88.21% 5.61 8.49 -33.92% 10.77 7.52 43.22%
Interest 2.23 3.26 -31.60% 3.09 3.92 -21.17% 3.18 3.80 -16.32% 3.73 3.33 12.01%
Depreciation 10.95 8.65 26.59% 8.87 8.87 0.00% 9.03 8.61 4.88% 8.90 8.63 3.13%
PBT 2.65 13.71 -80.67% 22.79 19.09 19.38% -12.15 22.45 - -3.33 25.90 -
Tax 0.07 0.00 0 0.00 -0.04 - 0.00 0.00 0 0.00 0.00 0
PAT 2.58 13.71 -81.18% 22.78 19.13 19.08% -12.15 22.45 - -3.33 25.90 -
PATM 0.85% 7.93% 9.59% 8.06% -5.86% 10.33% -1.72% 11.63%
EPS 0.54 2.94 -81.63% 4.69 4.40 6.59% -2.49 4.10 - -1.13 5.37 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 942.57 921.93 819.37 665.90 556.97 450.69 481.21 583.65 644.17 755.36 879.34 Net Sales Growth 10.83% 12.52% 23.05% 19.56% 23.58% -6.34% -17.55% -9.40% -14.72% -14.10% Cost Of Goods Sold 631.31 544.22 484.46 384.62 314.07 229.27 200.31 278.16 330.87 367.46 419.31 Gross Profit 311.26 377.70 334.91 281.28 242.90 221.42 280.90 305.49 313.30 387.89 460.03 GP Margin 33.02% 40.97% 40.87% 42.24% 43.61% 49.13% 58.37% 52.34% 48.64% 51.35% 52.32% Total Expenditure 896.40 811.32 708.57 581.60 498.27 391.92 469.81 589.95 621.96 663.28 705.28 Power & Fuel Cost - 64.98 62.92 61.26 52.74 39.31 47.44 48.76 50.69 54.33 55.28 % Of Sales - 7.05% 7.68% 9.20% 9.47% 8.72% 9.86% 8.35% 7.87% 7.19% 6.29% Employee Cost - 86.36 69.64 65.35 60.21 64.40 71.60 79.14 82.39 75.44 82.63 % Of Sales - 9.37% 8.50% 9.81% 10.81% 14.29% 14.88% 13.56% 12.79% 9.99% 9.40% Manufacturing Exp. - 50.69 39.75 35.55 32.88 29.09 50.71 54.64 63.08 85.12 91.48 % Of Sales - 5.50% 4.85% 5.34% 5.90% 6.45% 10.54% 9.36% 9.79% 11.27% 10.40% General & Admin Exp. - 22.25 22.22 14.26 10.80 15.23 42.43 28.21 38.52 38.42 28.04 % Of Sales - 2.41% 2.71% 2.14% 1.94% 3.38% 8.82% 4.83% 5.98% 5.09% 3.19% Selling & Distn. Exp. - 24.14 23.86 14.34 20.35 11.52 6.42 7.40 14.62 35.43 21.35 % Of Sales - 2.62% 2.91% 2.15% 3.65% 2.56% 1.33% 1.27% 2.27% 4.69% 2.43% Miscellaneous Exp. - 18.67 5.72 6.22 7.22 3.10 50.91 93.64 41.79 7.07 21.35 % Of Sales - 2.03% 0.70% 0.93% 1.30% 0.69% 10.58% 16.04% 6.49% 0.94% 0.82% EBITDA 46.16 110.61 110.80 84.30 58.70 58.77 11.40 -6.30 22.21 92.08 174.06 EBITDA Margin 4.90% 12.00% 13.52% 12.66% 10.54% 13.04% 2.37% -1.08% 3.45% 12.19% 19.79% Other Income 49.37 45.24 30.65 19.43 9.00 6.46 24.28 16.93 19.87 19.48 24.60 Interest 12.19 14.93 16.71 32.90 33.46 52.21 6.22 6.68 310.25 331.10 294.23 Depreciation 37.81 34.44 33.22 54.79 87.02 108.90 117.91 129.92 133.29 139.42 143.41 PBT 38.94 106.48 91.52 16.04 -52.77 -95.87 -88.46 -125.99 -401.47 -358.96 -238.98 Tax 0.00 0.00 -3.23 0.00 0.00 0.00 0.00 0.00 -46.19 -48.04 -17.25 Tax Rate 0.00% 0.00% -3.53% 0.00% 0.00% 0.00% 0.00% 0.00% 11.51% 9.04% 5.92% PAT 38.94 106.48 94.75 55.25 -52.77 -95.87 -88.46 -101.05 -355.28 -483.63 -274.27 PAT before Minority Interest 38.94 106.48 94.75 55.25 -52.77 -95.87 -88.46 -101.05 -355.28 -483.63 -274.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.13% 11.55% 11.56% 8.30% -9.47% -21.27% -18.38% -17.31% -55.15% -64.03% -31.19% PAT Growth -59.26% 12.38% 71.49% - - - - - - - EPS 7.68 21.00 18.69 10.90 -10.41 -18.91 -17.45 -19.93 -70.07 -95.39 -54.10

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 942.57 921.93 819.37 665.90 559.56 450.06 483.80 599.98 682.98 796.50 873.44 Net Sales Growth 10.83% 12.52% 23.05% 19.00% 24.33% -6.97% -19.36% -12.15% -14.25% -8.81% Cost Of Goods Sold 631.31 544.22 484.46 384.62 313.56 228.51 203.35 289.70 350.20 393.46 400.96 Gross Profit 311.26 377.70 334.91 281.28 246.00 221.56 280.45 310.28 332.79 403.05 472.47 GP Margin 33.02% 40.97% 40.87% 42.24% 43.96% 49.23% 57.97% 51.72% 48.73% 50.60% 54.09% Total Expenditure 901.61 811.33 708.58 581.60 504.98 399.40 453.61 611.80 658.68 709.37 702.65 Power & Fuel Cost - 64.98 62.92 61.26 52.74 39.31 47.44 48.76 50.69 54.33 55.28 % Of Sales - 7.05% 7.68% 9.20% 9.43% 8.73% 9.81% 8.13% 7.42% 6.82% 6.33% Employee Cost - 86.36 69.64 65.35 63.28 67.11 74.86 82.28 86.22 80.25 86.81 % Of Sales - 9.37% 8.50% 9.81% 11.31% 14.91% 15.47% 13.71% 12.62% 10.08% 9.94% Manufacturing Exp. - 50.69 39.75 35.55 32.88 29.10 53.25 55.98 65.65 87.40 94.33 % Of Sales - 5.50% 4.85% 5.34% 5.88% 6.47% 11.01% 9.33% 9.61% 10.97% 10.80% General & Admin Exp. - 22.25 22.22 14.26 13.03 18.34 43.67 30.72 41.49 40.99 31.10 % Of Sales - 2.41% 2.71% 2.14% 2.33% 4.08% 9.03% 5.12% 6.07% 5.15% 3.56% Selling & Distn. Exp. - 24.14 23.86 14.34 22.26 13.46 8.14 10.34 22.10 26.19 27.73 % Of Sales - 2.62% 2.91% 2.15% 3.98% 2.99% 1.68% 1.72% 3.24% 3.29% 3.17% Miscellaneous Exp. - 18.68 5.73 6.22 7.22 3.59 22.89 94.02 42.34 26.75 27.73 % Of Sales - 2.03% 0.70% 0.93% 1.29% 0.80% 4.73% 15.67% 6.20% 3.36% 0.74% EBITDA 40.94 110.60 110.79 84.30 54.58 50.66 30.19 -11.82 24.30 87.13 170.79 EBITDA Margin 4.34% 12.00% 13.52% 12.66% 9.75% 11.26% 6.24% -1.97% 3.56% 10.94% 19.55% Other Income 25.55 34.45 31.13 19.43 9.00 15.21 24.28 16.93 20.30 19.17 24.91 Interest 12.23 14.93 16.74 32.90 33.46 52.21 6.23 6.69 310.26 331.11 294.24 Depreciation 37.75 34.55 33.24 54.79 87.02 108.92 117.93 129.94 133.31 141.02 145.27 PBT 9.96 95.56 91.95 16.04 -56.90 -95.25 -69.69 -131.52 -398.96 -365.82 -243.82 Tax 0.07 -0.19 -3.12 0.00 0.00 0.00 0.00 0.00 -46.19 -48.04 -17.25 Tax Rate 0.70% -0.20% -3.39% 0.00% 0.00% 0.00% 0.00% 0.00% 11.58% 8.92% 5.82% PAT 9.88 95.76 95.06 55.25 -56.90 -95.25 -69.69 69.41 -352.77 -490.49 -279.11 PAT before Minority Interest 9.88 95.76 95.06 55.25 -56.90 -95.25 -69.69 69.41 -352.77 -490.49 -279.11 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.05% 10.39% 11.60% 8.30% -10.17% -21.16% -14.40% 11.57% -51.65% -61.58% -31.96% PAT Growth -87.83% 0.74% 72.05% - - - - - - - EPS 1.95 18.89 18.75 10.90 -11.22 -18.79 -13.75 13.69 -69.58 -96.74 -55.05

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,324.05 1,218.32 731.96 677.95 681.34 797.83 -754.99 -674.13 -263.83 171.13 Share Capital 50.72 50.72 40.82 40.82 40.82 40.82 88.96 88.96 88.96 88.96 Total Reserves 1,273.33 1,167.60 691.15 637.14 640.52 757.01 -843.95 -763.10 -352.80 82.17 Non-Current Liabilities 135.06 124.21 164.67 222.40 442.26 518.98 1,435.53 1,904.62 2,204.95 2,475.41 Secured Loans 0.00 0.00 40.09 110.84 341.60 429.50 1,424.61 1,893.91 2,156.78 2,377.54 Unsecured Loans 131.64 120.21 108.75 97.32 85.90 74.47 0.00 0.00 0.00 0.00 Long Term Provisions 3.39 3.63 12.60 11.01 11.54 11.79 7.70 7.48 2.07 3.73 Current Liabilities 237.47 209.67 326.63 193.83 100.87 133.18 2,312.71 1,980.28 1,519.64 1,315.98 Trade Payables 170.48 179.39 129.11 120.74 68.74 60.21 269.93 326.85 403.68 353.09 Other Current Liabilities 22.03 14.15 53.09 47.25 25.76 69.72 1,343.66 958.10 476.00 285.05 Short Term Borrowings 42.60 14.05 140.95 22.84 2.84 0.00 695.49 694.29 599.52 633.62 Short Term Provisions 2.37 2.08 3.49 3.01 3.52 3.25 3.63 1.03 40.44 44.22 Total Liabilities 1,696.58 1,552.20 1,223.26 1,094.18 1,224.47 1,449.99 2,993.25 3,210.77 3,460.76 3,962.52 Net Block 613.25 616.43 573.06 583.65 670.39 857.86 1,161.35 1,291.28 1,401.71 1,540.36 Gross Block 1,328.11 1,297.02 1,220.45 1,176.26 1,175.97 1,246.98 1,424.57 1,424.57 2,893.25 2,893.19 Accumulated Depreciation 714.87 680.59 647.39 592.60 505.58 389.12 263.22 133.29 1,491.54 1,352.83 Non Current Assets 910.19 769.91 729.46 711.12 682.22 885.22 2,209.79 2,519.97 2,507.72 2,638.40 Capital Work in Progress 43.91 24.46 46.09 9.78 7.43 25.61 278.16 271.53 288.31 280.40 Non Current Investment 69.35 69.40 50.12 49.01 0.40 0.34 0.47 124.77 124.66 124.65 Long Term Loans & Adv. 183.67 59.61 60.20 68.66 3.98 1.41 759.97 822.41 686.62 681.08 Other Non Current Assets 0.02 0.02 0.00 0.01 0.01 0.00 9.84 9.98 6.42 11.91 Current Assets 786.39 782.29 493.79 369.78 421.40 564.77 783.46 690.80 953.03 1,324.12 Current Investments 0.00 0.00 0.00 0.00 15.02 0.00 0.00 0.00 0.00 0.00 Inventories 326.37 264.23 228.74 172.66 150.57 140.78 167.11 184.94 197.45 210.34 Sundry Debtors 241.83 189.37 211.91 160.23 131.96 66.38 140.73 145.06 246.42 375.44 Cash & Bank 164.28 257.23 22.34 4.21 18.97 172.32 324.17 301.04 256.04 313.11 Other Current Assets 53.91 6.80 3.64 12.86 104.89 185.29 151.45 59.75 253.12 425.23 Short Term Loans & Adv. 49.24 64.67 27.17 19.83 95.63 163.95 127.86 40.31 244.22 308.82 Net Current Assets 548.92 572.62 167.16 175.95 320.53 431.59 -1,529.25 -1,289.49 -566.61 8.14 Total Assets 1,696.58 1,552.20 1,223.25 1,080.90 1,103.62 1,449.99 2,993.25 3,210.77 3,460.75 3,962.52

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,267.29 1,169.47 688.65 647.38 652.91 765.98 -704.04 -791.76 -387.67 49.04 Share Capital 50.72 50.72 40.82 40.82 40.82 40.82 88.96 88.96 88.96 88.96 Total Reserves 1,216.57 1,118.75 647.83 606.56 612.09 725.17 -793.00 -880.72 -476.63 -39.92 Non-Current Liabilities 134.96 124.43 164.67 222.40 442.26 518.98 1,435.53 1,904.62 2,204.95 2,475.41 Secured Loans 0.00 0.22 40.09 110.84 341.60 429.50 1,424.61 1,893.91 2,156.78 2,377.54 Unsecured Loans 131.64 120.21 108.75 97.32 85.90 74.47 0.00 0.00 0.00 0.00 Long Term Provisions 3.39 3.63 12.60 11.01 11.54 11.79 7.70 7.48 2.07 3.73 Current Liabilities 285.57 259.97 371.89 240.78 142.08 174.94 2,345.54 2,012.51 1,540.72 1,337.62 Trade Payables 222.09 229.58 174.37 167.68 109.95 101.59 302.45 358.79 424.52 374.27 Other Current Liabilities 18.51 14.27 53.09 47.25 25.76 70.10 1,343.97 958.40 476.24 285.34 Short Term Borrowings 42.60 14.05 140.95 22.84 2.84 0.00 695.49 694.29 599.52 633.79 Short Term Provisions 2.37 2.08 3.49 3.01 3.52 3.25 3.63 1.03 40.44 44.22 Total Liabilities 1,687.82 1,553.87 1,225.21 1,110.56 1,237.25 1,459.90 3,077.03 3,125.37 3,358.00 3,862.07 Net Block 632.71 620.23 573.09 583.70 670.45 857.93 1,256.26 1,386.20 1,496.54 1,636.83 Gross Block 1,347.82 1,300.94 1,220.56 1,176.39 1,176.10 1,247.11 1,519.52 1,519.16 3,005.92 3,005.87 Accumulated Depreciation 715.11 680.71 647.47 592.68 505.66 389.18 263.26 132.96 1,509.38 1,369.04 Non Current Assets 880.50 763.12 724.20 712.91 687.39 890.58 2,309.57 2,446.42 2,478.86 2,610.87 Capital Work in Progress 80.71 30.67 46.46 9.78 7.43 25.61 278.16 271.53 288.31 280.40 Non Current Investment 49.67 45.82 44.44 45.49 0.40 0.34 0.47 1.07 0.96 0.81 Long Term Loans & Adv. 117.39 66.38 60.20 73.93 9.10 6.70 764.84 777.64 686.62 680.92 Other Non Current Assets 0.02 0.02 0.00 0.01 0.01 0.00 9.84 9.98 6.42 11.91 Current Assets 807.32 790.75 501.01 384.36 429.01 569.32 767.46 678.94 879.14 1,251.20 Current Investments 0.00 0.00 0.00 0.00 15.02 0.00 0.00 0.00 0.00 0.00 Inventories 326.37 264.23 228.74 172.66 152.89 141.69 169.77 193.74 211.25 241.85 Sundry Debtors 241.83 195.55 215.19 170.57 135.70 67.97 119.89 119.51 203.00 310.07 Cash & Bank 179.63 266.57 30.63 8.06 19.91 174.04 325.52 305.55 257.06 314.94 Other Current Assets 59.48 7.05 3.95 13.01 105.49 185.62 152.28 60.14 207.82 384.34 Short Term Loans & Adv. 53.97 57.36 22.50 20.07 95.87 164.05 140.27 40.31 198.36 267.62 Net Current Assets 521.75 530.78 129.12 143.58 286.92 394.39 -1,578.08 -1,333.57 -661.58 -86.42 Total Assets 1,687.82 1,553.87 1,225.21 1,097.27 1,116.40 1,459.90 3,077.03 3,125.36 3,358.00 3,862.07

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 27.48 130.73 13.39 89.57 24.36 80.42 15.18 5.58 317.68 211.30 PBT 106.48 91.52 54.19 -4.81 -117.15 -149.84 -101.05 -401.47 -445.42 -291.52 Adjustment 23.52 41.68 54.10 38.24 163.69 174.58 235.19 449.77 575.53 495.56 Changes in Working Capital -101.58 -3.22 -94.60 58.04 -27.10 45.25 -114.68 -35.68 187.56 7.26 Cash after chg. in Working capital 28.42 129.99 13.69 91.47 19.44 70.00 19.46 12.62 317.68 211.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.94 0.74 -0.30 -1.91 4.92 10.42 -4.28 -7.04 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -37.35 -315.81 -26.70 112.93 67.21 167.12 45.48 -27.95 -8.62 -1.23 Net Fixed Assets -50.54 -54.94 -80.50 -2.64 89.19 430.14 -6.63 1,485.46 -7.97 -2.38 Net Investments 0.05 -19.28 -1.11 -33.59 -15.08 0.13 124.30 -0.11 -0.01 0.00 Others 13.14 -241.59 54.91 149.16 -6.90 -263.15 -72.19 -1,513.30 -0.64 1.15 Cash from Financing Activity 25.44 167.07 31.17 -216.80 -164.99 -250.33 -0.30 33.39 -366.12 -286.52 Net Cash Inflow / Outflow 15.58 -18.01 17.86 -14.30 -73.42 -2.79 60.36 11.02 -57.07 -76.45 Opening Cash & Equivalents 0.29 18.31 0.45 14.75 88.17 90.97 30.60 19.58 313.11 389.57 Closing Cash & Equivalent 15.87 0.29 18.31 0.45 14.75 88.17 90.97 30.60 256.04 313.11

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 19.22 125.99 18.34 92.47 23.59 80.80 12.02 9.18 317.01 212.20 PBT 99.46 89.05 46.32 -1.95 -116.53 -131.07 69.41 -398.96 -452.28 -296.18 Adjustment 29.22 44.15 51.38 36.77 172.15 139.57 57.34 453.49 582.11 490.19 Changes in Working Capital -108.53 -7.84 -79.06 59.57 -36.96 61.89 -110.44 -38.31 187.17 18.19 Cash after chg. in Working capital 20.15 125.36 18.64 94.38 18.66 70.38 16.30 16.22 317.01 212.20 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.94 0.63 -0.30 -1.91 4.92 10.42 -4.28 -7.04 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -26.93 -312.03 -31.21 112.94 67.21 167.11 45.47 -28.06 -8.59 -1.46 Net Fixed Assets -50.54 -54.94 -80.50 -2.64 89.19 430.14 -6.63 1,485.46 -7.97 -2.38 Net Investments 0.05 -19.28 -1.11 -33.59 -15.08 0.13 124.30 -0.11 -0.01 0.00 Others 23.56 -237.81 50.40 149.17 -6.90 -263.16 -72.20 -1,513.41 -0.61 0.92 Cash from Financing Activity 25.22 167.04 31.17 -216.80 -164.99 -250.33 -0.30 33.39 -366.30 -286.36 Net Cash Inflow / Outflow 17.51 -19.00 18.29 -11.39 -74.20 -2.42 57.20 14.51 -57.88 -75.62 Opening Cash & Equivalents 3.60 22.60 4.31 15.69 89.89 92.31 35.11 20.60 314.94 390.56 Closing Cash & Equivalent 21.11 3.60 22.60 4.31 15.69 89.89 92.31 35.11 257.06 314.94

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 261.06 240.21 179.33 166.10 166.93 195.47 -84.86 -75.78 -29.66 19.24 ROA 6.56% 6.83% 4.77% -4.55% -7.17% -6.74% -3.26% -10.65% -13.03% -6.76% ROE 8.38% 9.72% 7.84% -7.76% -12.96% -699.60% 0.00% 0.00% 0.00% -89.85% ROCE 8.52% 8.96% 8.77% -1.86% -3.50% -7.48% -3.77% -3.40% -6.44% 0.08% Fixed Asset Turnover 0.70 0.65 0.56 0.47 0.37 0.36 0.41 0.30 0.26 0.31 Receivable days 85.36 89.38 101.99 95.74 80.31 78.55 89.36 110.08 148.10 136.50 Inventory Days 116.91 109.80 110.01 105.91 117.98 116.77 110.08 107.53 97.12 92.83 Payable days 117.32 116.21 118.55 110.10 102.64 113.51 182.54 192.92 181.33 144.12 Cash Conversion Cycle 84.95 82.96 93.45 91.55 95.64 81.81 16.91 24.69 63.90 85.21 Total Debt/Equity 0.13 0.11 0.45 0.40 0.66 0.71 -4.28 -4.75 -11.77 18.78 Interest Cover 8.13 6.48 2.68 -0.58 -0.84 -23.07 -14.12 -0.29 -0.61 0.01

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 249.86 230.58 168.72 158.61 159.96 187.67 -79.14 -89.00 -43.58 5.51 ROA 5.91% 6.84% 4.73% -4.85% -7.06% -5.78% 2.24% -10.88% -13.59% -7.05% ROE 7.86% 10.23% 8.27% -8.75% -13.43% -423.17% 0.00% 0.00% 0.00% -147.51% ROCE 8.05% 9.35% 9.11% -2.32% -3.53% -6.47% 3.08% -3.46% -6.93% -0.06% Fixed Asset Turnover 0.70 0.65 0.56 0.48 0.37 0.35 0.39 0.30 0.27 0.29 Receivable days 86.58 91.49 105.72 99.89 82.59 70.86 72.82 85.57 115.97 116.98 Inventory Days 116.91 109.80 110.01 106.18 119.45 117.49 110.57 107.46 102.41 101.94 Payable days 151.46 152.17 162.30 161.59 168.95 136.49 197.80 198.57 186.30 148.72 Cash Conversion Cycle 52.03 49.12 53.43 44.47 33.09 51.86 -14.40 -5.54 32.07 70.20 Total Debt/Equity 0.14 0.12 0.48 0.41 0.69 0.74 -4.59 -4.04 -8.01 65.54 Interest Cover 7.40 6.49 2.68 -0.70 -0.82 -20.04 11.38 -0.29 -0.63 -0.01

Top Investors:

quant mutual fund - quant small cap fund

kotak mahindra trustee co ltd a/c kotak consumption fund and 7 others

uti small cap fund and 3 others

invesco india contra fund and 2 others

bandhan small cap fund and 5 others

Annual Reports:

News Update:

Orchid Pharma signs licensing and supply agreement with Pharmasyntez
8th Jul 2026, 09:16 AM

Under the agreement, Pharmasyntez will hold the exclusive rights to register and commercialize Exblifep in Russia, with Orchid supplying the finished dosage form
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback